Home › NCT06041763

Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair

Outcomes Following Meniscal Repair With the BEAR Implant: A Randomized Controlled Trial

Who can join

Ages 18 to 75 · All sexes

Inclusion Criteria:

• History of meniscus injury indicated for isolated repair, without concomitant ligament reconstruction or repair, cartilage repair procedure, or osteotomy.

Exclusion Criteria:

* Patients who are undergoing meniscal repair for displaced bucket-handle meniscal tears
* Patients with a history of blood-borne diseases including HIV, hepatitis B virus, hepatitis C virus, human T-lymphotropic virus, and syphilis

About the study

The bridge-enhanced ACL repair (BEAR) implant is a collagen-based scaffold loaded with whole blood. It is designed to promote healing in the setting of intraarticular knee pathology. This study would compare clinical outcomes and synovial fluid cytokine profiles in patients who undergo isolated meniscal repair with or without the BEAR implant.

What is being tested

• Meniscal Repair Procedure (procedure)
• BEAR Implant (device)

Sponsor: NYU Langone Health · Participants: 80 · Started: Nov 20, 2024

Contact the study team

• Emma Trasatti · Phone: 856-885-3259
• Samy Shelbaya · Phone: 517-575-5522

Official record on ClinicalTrials.gov — NCT06041763

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.